Antisense peptide nucleic acids (PNAs) can inhibit Escherichia coli gene expression and cell growth through sequence-specific RNA binding, and this opens possibilities for novel anti-infective agents and tools for microbial functional genomics. However, the cellular effects of PNAs are limited relative to effects in cell extracts, presumably because of cell barrier components such as the outer-membrane lipopolysaccharide (LPS) layer or drug efflux pumps, both of which function to exclude antibiotics and other foreign molecules. To evaluate the importance of such cellular factors on PNA effects, the authors developed a positive assay for antisense inhibition by targeting the lac operon repressor and compared PNA susceptibilities in mutant and wild-type E. coli by assessing lacZ induction. Strains with defective LPS (AS19 and D22) were more permeable to the antibiotic nitrocefin and more susceptible to PNA than the wild-type. Also, PNA potency was improved in wild-type cells grown in the presence of certain cell-wall-permeabilizing agents. In contrast, the activities of the Acr and Emr drug efflux pumps were not found to affect PNA susceptibility. The results show that the LPS layer is a major barrier against cell entry, but PNAs that can enter E. coli are likely to remain active inside cells.
INTRODUCTION
Bacteria possess endogenous antisense gene control mechanisms (Simons & Kleckner, 1988) , and recent experiments show that antisense gene inhibition in bacteria is possible using synthetic antisense agents. Peptide nucleic acids (PNAs) targeted to RNA components of the ribosome can inhibit translation and cell growth, and PNAs targeted to mRNA can limit gene expression with gene and sequence specificity (Good & Nielsen, 1998a, b) . Therefore, PNAs can provide tools for functional analyses of bacterial genes and there are attractive possibilities for novel sequence-designed antiinfective agents (Good & Nielsen, 1998a, b ; Ecker & Freier, 1998) . To improve the approach, the challenge is to learn more about cellular limits to PNA activity and design molecules to more efficiently enter cells and access RNA targets. PNA is a DNA mimic with nucleobases attached to a pseudopeptide backbone (Nielsen et al., 1991) (Fig. 1a) . PNA hybridizes to complementary DNA, RNA or PNA oligomer sequences through Watson and Crick base pairing and helix formation (Egholm et al., 1993 ; Wittung et al., 1994 ; Jensen et al., 1997) . The peptide backbone provides improved hybridization affinity and specificity properties (Egholm et al., 1993 ; Jensen et al., 1997) , resistance to enzymic degradation (Demidov et al., 1994) and access to a variety of chemical modifications (Nielsen & Haaima, 1997 ; Pu$ schl et al., 1998) . For antisense applications, target-bound PNA can hinder the activities of DNA and RNA polymerases, reverse transcriptase, telomerase and the ribosome (Hanvey et al., 1992 ; Knudsen & Nielsen, 1996 ; Good & Nielsen, 1998a) . Also, in vitro assays for telomerase activity and mitochondrial genome replication show that PNAs are often effective in applications where other (modified) oligonucleotides perform poorly (Norton et al., 1996 ; Taylor et al., 1997) .
Limited cellular uptake is a general difficulty with antisense agents. Furthermore, restricted uptake is expected with Escherichia coli because of stringent 0002-4226 # 2000 SGM cellular barriers against foreign molecules (Nikaido, 1994) . The outer barrier of Gram-negative bacteria consists of a peptidoglycan layer, a lipid bilayer and an external lipopolysaccharide (LPS) coating. Furthermore, foreign compounds that do enter cells can be exported by various translocases, which are believed to ' pump out ' a wide range of foreign compounds including certain peptides (Nikaido, 1994 ; Lewis, 1994) . Therefore, typical bacterial cells are well equipped to resist foreign molecules, such as PNA. Indeed, results from cell extract and cell culture experiments suggest that only a small proportion of PNAs can enter and act within cells (Good & Nielsen, 1998a, b) .
To study factors that limit PNA antisense effects apart from nonspecific inhibition, we designed a PNA to target the lac repressor mRNA. Limited repressor expression was seen as induced β-galactosidase (LacZ) activity in E. coli cells and taken as an indicator of antisense effect. The anti-lac repressor PNA was used together with mutant E. coli strains and chemicals known to disrupt cell wall components. The results show that the outer-membrane LPS layer is a major limit to PNA cell entry and antisense effects in E. coli.
METHODS
Bacteria and plasmids. The E. coli strains used in this study are listed in Tables 1 and 3 . Plasmid pBX1, which carries a wild-type copy of the acr operon, was obtained from Kevin Bertrand (Washington State University), and plasmid pEMR2.1, which carries a wild-type copy of the emrB drug translocase, was obtained from Kim Lewis (Tufts University).
PNAs and other chemicals. The PNAs used in this study were synthesized as described by Christensen et al. (1995) , and their structures are shown in Fig. 1 . The cell-wall-active chemicals were from Sigma and the nitrocefin was from Oxoid.
Bacterial growth conditions. Growth on solid media was initiated with an inoculum of 10% cells ml − " in an overlay of agar media, and growth in liquid media was initiated with an inoculum of 10% cells ml − " in 200 µl cultures in siliconized polypropylene microdilution tubes. The cultures were grown in 10 % Luria-Bertani medium at 37 mC for 18 h. The chemicals listed in Table 2 were included in liquid cultures over the nanomolar concentration range. PNAs and the chemicals listed in Table 2 were added to cultures prior to overnight growth. β-Galactosidase activity assays. To indicate LacZ activity in solid cultures, the chromogenic substrate X-Gal was included in the agar plates at 250 µg ml − " and 4 µl PNA aliquots of PNA were applied by pipette directly onto the agar surface before growth. β-Galactosidase activity in liquid cultures was measured by using the chromogenic LacZ substrate ONPG, essentially as described by Miller (1972) .
Nitrocefin outer cell barrier permeability assay. Outermembrane permeability was determined essentially as described by Angus (1982) . E. coli cells transformed with pBR322 were cultured to mid-exponential phase, recovered by centrifugation at 3000 g and rinsed with 5 mM HEPES (7n4). Reactions were in 96-well microtitre plates containing 0n1 OD &&! units of cells in 5 mM HEPES (7n4), 5 mM carbonyl cyanide m-chlorophenylhydrazone (CCCP), and 20 µg nitrocefin ml − ". Nitrocefin cleavage was monitored by measuring A &!! .
RESULTS AND DISCUSSION

PNA-mediated up-regulation of the lac operon
To establish a positive assay for PNA antisense effects, we designed a new PNA (F1709) to target the start codon region of the E. coli lac repressor gene (lacI). The lacI gene normally represses the lac operon and limits expression of the lacZ gene (Miller, 1972) . To test the potential of the anti-lacI antisense strategy, PNA F1709 was applied to a lawn of E. coli AS19 cells grown on an LB agar plate containing the LacZ substrate X-Gal, but not the lac operon inducer IPTG (Fig. 1) . Increased lacZ expression was apparent as blue zones at sites of antisense PNA application (Fig. 1) . Control PNAs did not up-regulate lacZ. Therefore, induction of lacZ by PNA F1709 provides a positive assay for PNA antisense effects. The assay can be used to assess factors that limit (Miller, 1972) . Outer-membrane permeability to nitrocefin (Angus et al., 1982) was determined using cells carrying the β-lactamase gene within pBR322. CGSC indicates the Coli Genetic Stock Center, Yale University. or improve the antisense approach, apart from nonspecific inhibitory effects.
Strain
LPS layer and limited antisense effects
The outer cell membrane of Gram-negative bacteria is coated with an LPS layer that stringently limits the influx of foreign molecules (Nikaido, 1994 ; Hancock, 1997) , and this barrier also may restrict PNA. In our previous experiments, efficient inhibition in vitro was observed with PNA concentrations in the nanomolar range, whereas growth inhibition in cells required micromolar concentrations, dilute growth medium and the cell-wall-deficient strain AS19 (Good & Nielsen, 1998a, b) . These results suggest that cell uptake, rather than limited intracellular activities, is the major limit against the use of antisense PNAs in bacteria. Therefore, we aimed to determine whether PNA susceptibility correlates with outer-barrier permeability and whether PNA antisense effects can be improved by compromising the integrity of the LPS. It was hoped that the results would clarify the need for improved uptake properties in the next generation of antisense PNAs.
Wild-type and permeable mutant E. coli strains were tested for susceptibility to antisense PNA F1709. Among the strains listed in Table 1 , AS19 and to a lesser extent D22 showed increased induction of lacZ by PNA F1709 ; both of these susceptible strains are LPS defective. Strain AS19 has a severely depleted LPS layer (Zorzopulos et al., 1989) and is more susceptible to antibiotics (Sekiguchi & Iida, 1967) . Also, this strain is unusually susceptible to PNAs targeted to the rRNA and reporter gene mRNAs (Good & Nielsen, 1998b Induction of the lac operon was measured by assaying LacZ activity after growth in the presence and absence of PNA (2 µM) and a range of polymyxin B nonapeptide concentrations (see also Table 1 ). more susceptible to antibiotics (Normark et al., 1969) . Therefore, LPS defects in E. coli appear to confer unusual PNA susceptibility.
To establish a more direct link between LPS integrity and PNA susceptibility for strains AS19 and D22, we tested outer-barrier permeability to nitrocefin, a chromogenic cephaloporin antibiotic. Nitrocefin is normally excluded from cells, but nitrocefin molecules that do permeate the outer membrane are cleaved by periplasmic β-lactamase and undergo a change in absorbance maxi- mum from 385 nm to 490 (Angus et al., 1982) . E. coli strains were transformed with pBR322, selected for ampicillin resistance and subjected to the nitrocefin permeability assay (Table 1) . To block respiration and eliminate the potential for active efflux of nitrocefin, CCCP was included at 5 µM. The results showed high outer cell barrier permeability for strain AS19 and to a lesser extent for strain D22 (Table 1, Fig. 2 ). These strains also showed high PNA susceptibilities (Table 1) . The link between PNA susceptibility and LPS permeability suggests that the integrity of the LPS layer is a major determinant of PNA entry into E. coli.
To further investigate the importance of the LPS layer in the susceptibility of E. coli to PNA, we asked whether PNA antisense effects in wild-type E. coli strain K-12 can be improved by using chemicals that compromise LPS integrity. The anti-lac repressor PNA F1709 was used in combination with a range of compounds that permeabilize E. coli and can increase the uptake or potency of standard antibiotics ( Table 2) . Several of these agents enhanced PNA potency ; the most effective was polymyxin B nonapeptide, which enhanced lacZ induction by approximately sixfold when present at low nanomolar concentrations (Fig. 2 ). An important factor in the effectiveness of polymyxin B nonapeptide in this application may be its ability to permeabilize the outer membrane with relatively low toxicity to E. coli (Chunhong et al., 1998) . Antibiotics that block peptidoglycan formation did not enhance PNA effects (Table  2) . Synergism between polymyxin B nonapeptide and antisense PNAs is unlikely to be useful in practical applications, but it is important as further evidence that the LPS is a major barrier to PNA uptake.
Multidrug resistance translocase activity and PNA susceptibility
Intracellular accumulation of PNAs and antisense effects also could be limited by multidrug resistance translocases, which can clear a diverse range of foreign agents from cells, including peptide antibiotics (Shafer et al., 1998) . Several drug translocases are associated with multidrug-resistance phenotypes in bacteria, and these ' efflux pumps ' display surprising substrate flexibility. Therefore, we investigated whether the best-known E. coli drug pumps could limit PNA-mediated effects. The level of lacZ induction by PNA F1709 was determined in E. coli strains with altered drug efflux activities. Strains with defective copies of the acrAB or emrA transporter genes did not differ from the wild-type in susceptibility to PNAs (Table 3) . Also, plasmids bearing cloned copies of the acrA,B and emrB transporter genes were introduced by transformation to complement the defective endogenous genes in strains N43 and SJ261, and active copies of these genes did not alter PNA susceptibilies (Table 3) . The acr and emr drug translocase genes are among the best-characterized E. coli drug pumps, but other translocases also could affect PNA susceptibility. A range of translocases are implicated in drug resistance and there may be as many as 18 ABC-type transporter homologues within the E. coli genome (Blattner et al., 1997) . Accordingly, drug translocase involvement in PNA susceptibility was tested in a more general way using the inhibitors verapamil and reserpine, which can reduce drug efflux in E. coli and other types of cells (Beja & Bibi, 1996 ; Ng et al., 1994) . Neither of these compounds altered the PNA susceptibility of E. coli K-12. Therefore, PNA antisense effects in E. coli 
Conclusions
Induction of lacZ by an anti-lacI PNA provides a positive assay for antisense effects. In this study the assay was used to learn which cell-barrier components limit PNA cell entry and antisense effects in E. coli. The results, together with our previous work, provide three lines of evidence indicating that the LPS layer is a major barrier against PNA uptake. First, the LPS mutant strains AS19 and D22 are more susceptible to PNA than wild-type. Second, mutant E. coli strains that are more susceptible to PNA also are more permeable to the antibiotic nitrocefin. Third, chemical agents that compromise LPS integrity can also increase cellular PNA susceptibility. Fortunately, for practical applications, there are opportunities to modify PNAs to better permeate the outer-membrane LPS layer. Also, the activity of multidrug resistance translocases did not significantly alter the susceptibility of E. coli to PNA. This resistance against active efflux, along with evidence for PNA stability in biological fluids, suggests that PNAs that are able to gain access into bacteria are likely to remain active within cells. Therefore, efforts to improve the technology can focus on achieving improved uptake. Finally, the observation that an antisense PNA can upregulate, as well as down-regulate, gene expression supports the idea that antisense PNAs can provide sequence specific tools for the analysis of microbial gene expression and function.
